Literature DB >> 21410616

Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus.

Nina Kaur Hansra1, Kanade Shinkai.   

Abstract

The clinical presentation of methicillin-resistant Staphylococcus aureus (MRSA) infection ranges from asymptomatic colonization to cutaneous and invasive involvement. This review discusses the cutaneous presentations of community-acquired MRSA (CA-MRSA) and hospital-acquired MRSA (HA-MRSA) that one may encounter in the hospital or outpatient setting. Cutaneous CA-MRSA and HA-MRSA are often clinically indistinguishable, although they have different epidemiologic profiles and virulence factors. Bacterial culture is necessary for diagnosis and guides treatment, as infection with CA-MRSA and HA-MRSA require distinct clinical management. Guidelines for surgical interventions and antibiotic treatment of CA-MRSA and HA-MRSA will be discussed. Strategies for MRSA decolonization and prevention of further spread will also be reviewed.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21410616     DOI: 10.1111/j.1529-8019.2011.01402.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  8 in total

1.  Methicillin-resistant Staphylococcus aureus infection of the subacromial bursa: an unusual complication following subacromial corticosteroid injection (a report of two cases).

Authors:  Kar H Teoh; Sian A Jones; Subramaniam Gurunaidu; Mark G Pritchard
Journal:  Shoulder Elbow       Date:  2014-10-30

Review 2.  Resistant pathogens, fungi, and viruses.

Authors:  Christopher A Guidry; Sara A Mansfield; Robert G Sawyer; Charles H Cook
Journal:  Surg Clin North Am       Date:  2014-10-03       Impact factor: 2.741

3.  Structural analysis of Staphylococcus aureus serine/threonine kinase PknB.

Authors:  Sonja Rakette; Stefanie Donat; Knut Ohlsen; Thilo Stehle
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

4.  Analysis of Virulence Genes Among Methicillin Resistant Staphylococcus aureus (MRSA) Strains.

Authors:  Seyedeh Mahsan Hoseini Alfatemi; Mohammad Motamedifar; Nahal Hadi; Hadi Sedigh Ebrahim Saraie
Journal:  Jundishapur J Microbiol       Date:  2014-06-01       Impact factor: 0.747

5.  Antibacterial Activity of In Situ Prepared Chitosan/Silver Nanoparticles Solution Against Methicillin-Resistant Strains of Staphylococcus aureus.

Authors:  Viktoriia Holubnycha; Oksana Kalinkevich; Olena Ivashchenko; Maksym Pogorielov
Journal:  Nanoscale Res Lett       Date:  2018-03-02       Impact factor: 4.703

Review 6.  Insights into the epidemiology of community-associated methicillin-resistant Staphylococcus aureus in special populations and at the community-healthcare interface.

Authors:  Letícia Calixto Romero; Maria de Lourdes Ribeiro de Souza da Cunha
Journal:  Braz J Infect Dis       Date:  2021-10-19       Impact factor: 3.257

7.  Propionibacterium acnes strain populations in the human skin microbiome associated with acne.

Authors:  Sorel Fitz-Gibbon; Shuta Tomida; Bor-Han Chiu; Lin Nguyen; Christine Du; Minghsun Liu; David Elashoff; Marie C Erfe; Anya Loncaric; Jenny Kim; Robert L Modlin; Jeff F Miller; Erica Sodergren; Noah Craft; George M Weinstock; Huiying Li
Journal:  J Invest Dermatol       Date:  2013-01-21       Impact factor: 8.551

8.  Prevalence of methicillin-resistant Staphylococcus aureus colonization in individuals from the community in the city of Sao Paulo, Brazil.

Authors:  Taniela Marli Bes; Roberta Ruedas Martins; Lauro Perdigão; Diego Mongelos; Luisa Moreno; Andrea Moreno; Gerson Salvador de Oliveira; Silvia Figueiredo Costa; Anna Sara Levin
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-10-22       Impact factor: 1.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.